PI Industries reported a challenging Q4 FY26, with revenue at INR 15,652 Mn and Net Profit at INR 2,002 Mn, impacted by global agrochemical contractions. Despite the downcycle, the company demonstrated strong long-term resilience, achieving a 5-year Revenue CAGR of 8% and maintaining a robust balance sheet with INR 34,265 Mn in surplus cash. Strategic pivots toward Pharma, Biologicals, and new technology platforms continue to drive value creation and future growth.
Financial Performance Overview
For the quarter ended March 31, 2026, PI Industries faced significant headwinds, resulting in a 12% year-on-year decline in revenue to INR 15,652 Mn and a 39% dip in Net Profit to INR 2,002 Mn. For the full fiscal year FY26, revenue stood at INR 67,137 Mn with a Net Profit of INR 13,208 Mn. Despite these figures, the company maintained healthy operational discipline, achieving a Gross Margin of 58%, representing a 507 bps improvement over the previous year.
Strategic Business Highlights
The company continues to diversify its portfolio to mitigate sector-specific volatility. Notably, the Pharma business recorded strong growth, with a 40% year-on-year revenue increase in FY26. Furthermore, the company successfully commercialized 5 new molecules in its exports division and launched 4 new products in its domestic agri-brands segment. PI Industries’ commitment to innovation remains clear, with 90+ projects currently in the R&D pipeline.
Future Growth Engines
PI Industries is aggressively scaling its Biologicals segment, which has reached an annualized revenue of approximately USD 12 Mn with margins exceeding 60%. The company’s expansion into electronics and specialty chemicals, alongside its robust Pharma CRDMO capabilities, positions it for sustained long-term growth. With INR 11,508 Mn invested in Capex during FY26, the firm is strengthening its manufacturing and technological footprint to support future customer demand.
Sustainability and Recognition
Reinforcing its commitment to responsible business practices, PI Industries has been featured in the S&P Global Sustainability Yearbook for the third consecutive year and ranks in the top 2 percentile of ESG-rated companies globally. The Board has also signaled confidence in the company’s outlook by approving a final dividend of Rs 10 per share, bringing the total dividend for FY25-26 to Rs 15 per share.
Source: BSE
